Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
03/30/2006 | WO2005118643A3 Antibodies to angiogenesis inhibiting domains of cd148 |
03/30/2006 | WO2005117994A9 Bmp pathway methods and compositions |
03/30/2006 | WO2005113779A3 Plant myo-inositol kinase polynucleotides and methods of use |
03/30/2006 | WO2005084115A3 Ttg3 deficient plants, nucleic acids, polypetides and methods of use thereof |
03/30/2006 | WO2005072112A3 Methods for producing and identifying multispecific antibodies |
03/30/2006 | WO2005068612A3 Human hepatic progenitor cells and methods of use thereof |
03/30/2006 | WO2004096978A3 Production of high mannose proteins in plant culture |
03/30/2006 | WO2004076624A3 Compositions and methods for neural cell production and stabilization |
03/30/2006 | WO2004053071A3 Method for discovering neurogenic agents |
03/30/2006 | WO2004048594A3 Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences |
03/30/2006 | WO2003062369A3 Expansion of renewable stem cell populations |
03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
03/30/2006 | US20060070141 Method of repressing flowering in a plant |
03/30/2006 | US20060070140 Promoter molecules for use in plants |
03/30/2006 | US20060070139 Corn event DAS-59122-7 and methods for detection thereof |
03/30/2006 | US20060070138 Seed of cotton cultivar produced by crossing the cultivar 03X179R with itself or another cotton cultivar; insect resistance, herbicide resistance, sterility, enhanced fiber quality |
03/30/2006 | US20060070136 GLYT1 transgenic mouse |
03/30/2006 | US20060069246 Tumor necrosis factor receptor related proteins Tango-63d and Tango-63e |
03/30/2006 | US20060069242 Neurotrophic factor receptor |
03/30/2006 | US20060069053 Methods and compositions for enhancing cartilage repair |
03/30/2006 | US20060069050 Methods and compositions for mediating gene silencing |
03/30/2006 | US20060069025 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
03/30/2006 | US20060068497 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells |
03/30/2006 | US20060068496 Differentiation of stem cells |
03/30/2006 | US20060068495 Process of cell electrofusion |
03/30/2006 | US20060068494 WNT4 in supporting lymphopoiesis |
03/30/2006 | US20060068471 Soluble zcytor 11 cytokine receptors |
03/30/2006 | US20060068470 Antifreeze proteins from basidiomy cetes |
03/30/2006 | US20060068466 Used in assays for the identification of new agents for anesthesia and analgesia |
03/30/2006 | US20060068463 Natural killer cell activating factor ii |
03/30/2006 | US20060068453 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
03/30/2006 | US20060068439 Ucp4 |
03/30/2006 | US20060068423 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/30/2006 | US20060068413 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/30/2006 | US20060068404 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
03/30/2006 | US20060068370 Includes a proximal regulatory sequence and a distal enhancer of 5' flanking region of human alpha -fetoprotein (AFP) gene |
03/30/2006 | US20060068060 Carboxypeptidase of cocoa |
03/30/2006 | US20060067940 Monoclonal antibody or an antigen binding fragment that specifically binds amino acids of a West Nile virus E protein |
03/30/2006 | US20060067936 IL-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses |
03/30/2006 | US20060067918 Neural stem cell culture for prevention and treatment of brain and nervous sytem disorders |
03/30/2006 | US20060067916 Sperm cell process system |
03/30/2006 | US20060067914 Immortalized natural killer cell line |
03/30/2006 | US20060067912 Methods for the induction of professional and cytokine-producing regulatory T cells |
03/30/2006 | DE19824384B4 Herstellung von Primmorphen aus dissoziierten Zellen von Schwämmen und Korallen, Verfahren zur Kultivierung von Zellen von Schwämmen und Korallen zur Produktion und Detektion von bioaktiven Substanzen, zur Detektion von Umweltgiften und zur Kultivierung dieser Tiere in Aquarien und im Freiland Preparation of primmorphs from dissociated cells from sponges and corals, methods for culturing cells for the production of sponges, corals and detection of bioactive substances, for the detection of environmental toxins and for the cultivation of these animals in aquariums and in the open |
03/30/2006 | DE10105420B4 In vitro Zellinteraktionskultursystem für Medikamententestung und -entwicklung In vitro cell culture system for drug interaction testing and development |
03/30/2006 | CA2798495A1 Plant cells and plants with increased tolerance to environmental stress |
03/30/2006 | CA2581341A1 Genetic selection of small molecule modulators of protein-protein interactions |
03/30/2006 | CA2581237A1 Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc) |
03/30/2006 | CA2581091A1 Mycer immortalized hepatocyte |
03/30/2006 | CA2580975A1 Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof |
03/30/2006 | CA2580754A1 Compositions and methods for stem cell expansion and differentiation |
03/30/2006 | CA2580736A1 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use |
03/30/2006 | CA2577632A1 Intestinal epithelial glucose sensor |
03/30/2006 | CA2571272A1 Anti-lympho- plus anti-monocytes globulin preparation for inhibiting immune responses |
03/30/2006 | CA2521421A1 C-mycer.tam. induced human neural stem cell lines |
03/29/2006 | EP1640898A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
03/29/2006 | EP1640716A1 Blood cell separation membrane and blood retention tool including the same |
03/29/2006 | EP1640450A1 Process for producing retinal neurocyte from neural stem cell derived from iris tissue and retinal neurocyte produced by the process |
03/29/2006 | EP1640449A1 Cell differentiation inhibiting agent, cell culture method using the same, culture medium and cultured cell line |
03/29/2006 | EP1640448A2 Primate embryonic stem cells |
03/29/2006 | EP1640381A2 Neurotrophic growth factor |
03/29/2006 | EP1640024A2 Cell-coated support |
03/29/2006 | EP1639369A2 Plasma polymerisation methods for the deposition of chemical gradients and surfaces displaying a gradient of immobilised biomolecules |
03/29/2006 | EP1639112A2 Novel beta-actin and rps21 promoters and uses thereof |
03/29/2006 | EP1639111A2 Protein expression system |
03/29/2006 | EP1639109A2 Dna vectors |
03/29/2006 | EP1639099A1 Method of isolating cells from umbilical cord |
03/29/2006 | EP1639097A2 Methods and compositions for modulating stem cell growth and differentiation |
03/29/2006 | EP1639096A2 Methods of producing neurons |
03/29/2006 | EP1639095A2 Method to increase protein production in culture |
03/29/2006 | EP1639092A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
03/29/2006 | EP1639090A2 Compositions and methods for treating and diagnosing cancer |
03/29/2006 | EP1639089A2 Transcription factor |
03/29/2006 | EP1639013A2 Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy |
03/29/2006 | EP1639009A1 Fab library for the preparation of anti vegf and anti rabies virus fabs |
03/29/2006 | EP1639003A1 Use of cardiotrophin to modulate stem cell proliferation |
03/29/2006 | EP1639001A1 Method for transplanting lymphohematopoietic cells into mammal |
03/29/2006 | EP1638606A2 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
03/29/2006 | EP1638587A2 Contraceptive methods and compositions related to proteasomal interference |
03/29/2006 | EP1638507A2 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
03/29/2006 | EP1506294B1 Hydantoin racemase |
03/29/2006 | EP1434855A4 Adipose-derived stem cells and lattices |
03/29/2006 | EP1358354B1 Method for identifying compounds modulating reverse cholesterol transport |
03/29/2006 | EP1346039B1 Human cervical cancer 2 protooncogene and protein encoded therein |
03/29/2006 | EP1305402B1 Lipo-viro-particle complexes, preparation method and uses |
03/29/2006 | EP1222266B1 Pca3 messenger rna in benign and malignant prostate tissues |
03/29/2006 | EP1171006B1 Functionalized poly(propylene fumarate) and poly(propylene fumarate-co-ethylene glycol) |
03/29/2006 | EP1137943B1 Cancer detection method and reagents |
03/29/2006 | EP1088090B1 Inducible promoters |
03/29/2006 | EP1050542B1 Novel potassium channel protein |
03/29/2006 | EP1007627B1 Extracellular serine protease |
03/29/2006 | EP1005363B1 Recombinant dimeric envelope vaccine against flaviviral infection |
03/29/2006 | EP0990031B1 Tumor necrosis factor receptor 5 |
03/29/2006 | EP0961829B1 Fusion proteins for intracellular and intercellular transport and their uses |
03/29/2006 | EP0944722B1 Pituitary-tumor-transforming-genes, and related products |
03/29/2006 | EP0918797B1 Humanized immunoglobulin reactive with alpha4beta7 integrin |
03/29/2006 | EP0914427B1 Plasmid-based vaccine for treating atherosclerosis |
03/29/2006 | EP0837944B1 Mutated 5-enol pyruvylshikimate-3-phosphate synthase, gene coding for said protein and transformed plants containing said gene |
03/29/2006 | EP0832254B1 An autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes |
03/29/2006 | EP0751709B2 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |